Latest Southeast Asia News

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

PT ANTAM has raised its 2025 cash dividend by 38%, distributing Rp5.05 trillion to shareholders, reflecting strong profitability and a sustained commitment to shareholder returns.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.

OpenLearning has locked in a four-year SaaS contract with Holy Cross of Davao College, marking its biggest deal through the CE-Logic reseller channel and reinforcing its foothold in the Philippine education sector.

MyEco Group has finalised its operational overhaul, consolidating manufacturing in China and cutting fixed costs to sharpen its focus on sustainable packaging growth.

Lynas Rare Earths has deepened its footprint in Southeast Asia with a strategic A$50 million investment in JS Link’s new magnet factory in Malaysia, aiming to capture growth in automotive and renewable sectors.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.

Fluence Corporation has secured two seawater desalination contracts in Vietnam worth approximately US $3.7 million. The projects, set for completion by year-end 2026, will produce up to 7,500 cubic metres of potable water daily on Phu Quoc Island, addressing critical water scarcity.

Flagship Minerals has agreed to sell its RK Lithium Project in Thailand for US$4 million, accelerating its strategic pivot towards gold and copper assets in Chile and Canada.

Osteopore Limited has completed another incremental drawdown of A$250,000 on the second tranche of its redeemable convertible notes, continuing its steady funding progress under a A$20 million subscription agreement with Advance Opportunities Fund.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.